| 000 | 01035 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250518001502.0 | ||
| 008 | ####s 0 0 eng d | ||
| 022 | _a1178-6930 | ||
| 024 | 7 |
_a10.2147/OTT.S170303 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRedondo, Andrés | |
| 245 | 0 | 0 |
_aLong-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational "LORENA" study. _h[electronic resource] |
| 260 |
_bOncoTargets and therapy _c2018 |
||
| 300 |
_a5845-5852 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aRamos Vázquez, Manuel | |
| 700 | 1 | _aManso, Luis | |
| 700 | 1 | _aGil Gil, Miguel J | |
| 700 | 1 | _aGarau Llinas, Isabel | |
| 700 | 1 | _aGarcía-Garre, Elisa | |
| 700 | 1 | _aRodríguez, César A | |
| 700 | 1 | _aChacón, José Ignacio | |
| 700 | 1 | _aLópez-Vivanco, Guillermo | |
| 773 | 0 |
_tOncoTargets and therapy _gvol. 11 _gp. 5845-5852 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/OTT.S170303 _zAvailable from publisher's website |
| 999 |
_c28890062 _d28890062 |
||